Key Links

Keylinks Right Menu 

Licensure Key Links

Keylinks Licensure

The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) recently announced a nationwide shortage of penicillin G benzathine (Bicillin L-A) which is a first-line recommended treatment for syphilis. The Louisiana Department of Health (LDH) is aware of in-state providers experiencing challenges obtaining Bicillin L-A and is working closely with federal partners to monitor and mitigate the impacts of this shortage to the extent possible.

What should providers do during the Bicillin L-A shortage?

See the CDC Bicillin Shortage Announcement for additional clinical information: 

https://www.cdc.gov/std/treatment-guidelines/syphilis.htm

What should providers do if they experience shortages of Bicillin L-A?

 Luetkemeyer, A. F., et al. (2023). Post-exposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections, 

 Venkatesan, P. (2022). Doxycycline PEP for prevention of STIs. 